There are 2789 resources available
Discussion LBA63 and LBA64
Presenter: Gudrun Kreye
Session: Mini oral session - Supportive and palliative care
Resources:
Slides
Webcast
Discussion 1524MO and 1525MO
Presenter: Anna Maria Frezza
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast
Discussion 1759MO and 60MO
Presenter: Katsuya Tsuchihara
Session: Mini oral session - Translational research
Resources:
Slides
Webcast
Discussion LBA68, 1760MO, 1761MO and 61MO
Presenter: Bertrand Routy
Session: Mini oral session - Translational research
Resources:
Slides
Webcast
1526MO - GEMMK: A phase I study of gemcitabine (gem) and pembrolizumab (pem) in patients (pts) with leiomyosarcoma (LMS) and undifferentiated pleomorphic sarcoma UPS)
Presenter: Alannah Smrke
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
Discussion 1373MO, LBA10 and LBA37
Presenter: Changhoon Yoo
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Discussion LBA52, LBA53, LBA54 and LBA55
Presenter: Yelena Janjigian
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Discussion 960MO, 961MO and 962MO
Presenter: Thomas Gajewski
Session: Mini oral session - Investigational immunotherapy
Resources:
Slides
Webcast
LBA52 - Sintilimab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced or metastatic esophageal squamous cell cancer: First results of the phase III ORIENT-15 study
Presenter: Lin Shen
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
LBA53 - Sintilimab plus chemotherapy (chemo) versus chemo as first-line treatment for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (ORIENT-16): First results of a randomized, double-blind, phase III study
Presenter: Jianming Xu
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast